BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-253@pharmaconomics
DTSTAMP:20260707T034234Z
DTSTART;VALUE=DATE:20260630
DTEND;VALUE=DATE:20260701
SUMMARY:ZYME Catalyst — zanidatamab (estimated date)
DESCRIPTION:A key catalyst for zanidatamab (HER2+ gastric\, gastroesophageal junction\, or esophageal adenocarcinoma) is expected ~ Jun 30\, 2026.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1937653/000193765326000033/ex991q12026_earningsxrelea.htm\n\nTrack it: https://www.pharmaconomics.com/e/253
URL:https://www.pharmaconomics.com/e/253
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:ZYME catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR